Medisyn Technologies

	Medisyn Featured In Minnesota Business Magazine Minneapolis, March 3, 2003 - Medisyn Technologies CEO Jerry Mattys is featured in the March 2003 issue of Minnesota Business Magazine. The article in the Leading Edge section discusses how Medisyn's technology is used to discover and license new drug candidates for pharmaceutical companies looking to accelerate their drug discovery pipeline. Medisyn is a Twin Cities-based startup that continues the tradition of biotechnology innovation in Minnesota. The full article can be found in the printed version of Minnesota Business Magazine. About Medisyn Technologies Medisyn Technologies is a unique drug design and discovery company that uses proprietary technology to make drug discovery faster, more predictable and less expensive. Based on molecular topology, Medisyn’s Forward EngineeringTM platform enables the discovery and design of novel, diverse and unexpected compounds that meet exact parameters for a specific therapeutic use. By compressing design and discovery time from years to weeks and optimizing lead candidates, Medisyn’s novel approach enables drug discovery customers to reduce risk, improve probability of success and control costs associated with the traditional lead discovery process. The company is initially focused on treating cancer and is currently completing pre-clinical validation of MT103, a promising lead candidate for non-small cell lung cancer. It has an additional 26 anti-cancer compounds in varying stages of development. Medisyn Technologies is headquartered in Minneapolis, MN. For more information about Medisyn Technologies, visit the company’s website at: www.medisyntech.com or call 952.475.8084. Contact: Pam Pettinella LATITUDE 952.404.1853 pam@latitude-c.com Close Window